Lucien Israël

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Medicine, Immunology, Oncology +14

Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study.

Sylvie Négrier, Thierry Philip, G. Stoter et al. · PubMed · 1989 · 110 citations

Medicine, Immunology, Oncology +12

Brief Communication: Daily Intravenous Infusions of Corynebacterium parvum in Twenty Patients With Disseminated Cancer: A Preliminary Report of Clinical and Biologic Findings

Lucien Israël, R Edelstein, A Depierre et al. · JNCI Journal of the National Cancer Institute · 1975 · 76 citations

Medicine, Immunology, Oncology +14

Plasmapheresis in patients with disseminated cancer: Clinical results and correlation with changes in serum protein.The concept of “nonspecific blocking factors”

Lucien Israël, R Edelstein, P Mannoni et al. · Cancer · 1977 · 75 citations · Full text

Medicine, Oncology, Cancer Immunology +10

Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.

J H Edmonson, Stephen W. Lagakos, Oleg S. Selawry et al. · PubMed · 1976 · 73 citations

Medicine, Oncology, Pharmacotherapy +13